Approval · Notice of Compliance 856 · 2002
HERCEPTIN: Notice of Compliance 856
Issued February 27, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 856
- Date
- February 27, 2002
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing site
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HERCEPTIN | Not yet assigned | — |
Medicinal ingredients
- TRASTUZUMAB 440 MG per VIAL